Toxicological hazards of inhaled nanoparticles - Potential implications for drug delivery

Journal of Nanoscience and Nanotechnology

Volumn 4, Issue 5, 2004, Pages 521-531

  Borm, Paul J A ^a,c   Kreyling, Wolfgang ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c ZUYD UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

Author keywords

Drug Delivery; Inhalation; Nanoparticles; Systemic Effects; Toxicology

Indexed keywords

CARBON 13; DEXTRAN; DRUG CARRIER; GELATIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRIDIUM; MACROGOL; N (2 HYDROXYPROPYL)METHACRYLAMIDE; NICKEL; POLYGLACTIN; POLYGLUTAMIC ACID; POLYLACTIC ACID; SERUM ALBUMIN; TITANIUM DIOXIDE;

BLOOD BRAIN BARRIER; BLOOD CLOTTING; BLOOD FLOW; CALCIUM TRANSPORT; CARCINOGENICITY; CENTRAL NERVOUS SYSTEM; COMPLEX FORMATION; CONFERENCE PAPER; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; HEALTH HAZARD; HEART FUNCTION; HOMEOSTASIS; HUMAN; INFLAMMATION; INHALATION; LUNG; MACROPHAGE; NANOPARTICLE; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHAGOCYTOSIS; PROTEIN BINDING; SCREENING; TOXICOLOGY;

AEROSOLS; CARDIOVASCULAR DISEASES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FOREIGN-BODY REACTION; HUMANS; LUNG DISEASES; NANOSTRUCTURES; RISK ASSESSMENT; RISK FACTORS;

EID: 6344229772     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2004.081     Document Type: Conference Paper

References (78)

1. National Science & Technology Council, National Nanotechnology Initiative, Washington DC, (2000).
2. M. Meyer, O. Persson, and Y. Power, Mapping Excellence in Nanotechnologies, Brussel (2001).
3. D. W. Dockery, C. A. Pope 3rd, X. Xu, J. D. Spengler, J. H. Ware, M. E. Fay, B. G.Ferris Jr., and F. E. Speizer, N. Engl. J. Med. 329, 1753 (1993).
4. J. Samet, F. Dominici, F. C. Curriero, I. Coursac, and S. L. Zeger, N. Engl. J. Med. 343, 1742 (2000).
5. C. A. Pope 3rd, R. T. Burnett, M. J. Thun, E. E. Calle, D. Krewski, K. Ito, and G. D. Thurston, J. Am. Medic. Ass. 287, 1132 (2002).
6. G. Hoek, B. Brunekreef, S. Goldbohm, P. Fischer, and P. A. Van den Brandt Lancet 360, 1203 (2002).
7. G. Oberdörster, Int. Arch. Occup. Environ. Health 74, 1 (2000).
8. K. Donaldson, V. Stone, A. Clouter, L. Renwick, and W. MacNee, Occup. Environ. Med. 58, 211 (2001).
9. K. Donaldson, D. Brown, A. Clouter, R. Duffin, W. MacNee, L. Renwick, and V. Stone, J. Aerosol Med. 15, 213 (2002).
10. S. Salvi, and S. T. Holgate, Clin. Exp. Allergy 29, 1187 (1999).
11. A. E. Peters, H. E. Wichmann, T. Tuch, J. Heinrich, and J. Heyder, Am. J. Respir. Crit. Care Med. 155, 1376 (1997).
12. H-E Wichmann, C. Spix, T. Tuch, G. Wölke, A. Peters, J. Heinrich, W. G. Kreyling, J. Heyder, HEI report nr 98, Health Effect Institute, Boston, USA (2000).
13. Y. Matsumara and H. Maeda, Cancer Res. 6, 6387 (1986).
14. R. Duncan, in Biomedical Aspects of Drug Targeting, edited by V. R. Muzykantov and V. P. Torchilin, Kluwer Academic Publishers (2002), pp. 1-28.
15. J. Kreuter, D. Shamenkov, V. Petrov, P. Ramge, K.Cychutek, C. Koch-Brandt, and R. Alyautdin, J. Drug Target. 10, 317 (2002).
16. G. Oberdörster, J. Ferin, and B. E. Lehnert, Environ. Health Perspect. 102 (Suppl. 5), 173 (1994).
17. P. J. A. Borm, Inhalation Toxicol. 14, 101 (2002).
18. W. J. Bair, M. R. Bailey, F. T. Cross, R. G. Cuddihy, P. Gehr, A. C. James, J. R. Johnson, R. Masse, M. Roy, and W. Stahlhofen, ICRP Publication 66. Annals of the ICRP: 24 (1-3) (1994).
19. W. G. Kreyling and G. Scheuch, in Particle Lung Interactions, edited by P. Gehr and J. Heyder, Marcel Dekker, New York-Basel (2000), p. 323.
20. S. M. Moghimi and A. C. Hunter, Crit. Rev. Ther. Drug Carrier Syst. 18, 527 (2001).
21. I. Fenoglio, G. Martra, S. Coluccia, and B. Fubini, Chemical Res. Toxicol. 13, 971 (2000).
22. T. Suwa, J. C. Hogg, K. B. Quinlan, A. Ohgami, R. Vincent, and S. F. van Eeden, J. Am. Coll. Cardiol. 39, 943 (2002).
23. A. Nemmar, M. F. Hoylaerts, P. H. Hoet, D. Dinsdale, T. Smith, H. Xu, J. Vermeylen, and B. Nemery, Am. J. Respir. Crit. Care Med. 166, 998 (2002).
24. R. F. Service, Science 300, 243 (2003).
25. J. Ferin, G. Oberdörster, and D. P. Penney. Am. J. Respir. Cell Mol. Biol. 6, 535 (1992).
26. Q. Zhang, Y. Kusaka, K. Sato, K. Nakakuki, N. Kohyama, and K. Donaldson, J. Toxicol. Environ. Health 53, 423 (1998).
27. C. A. J. Dick, D. M. Brown, K. Donaldson, and V. Stone, Inhal. Toxicol. 15, 39 (2003).
28. V. Stone, M. Tuinman, J. E. Vamvakopoulos, J. Shaw, D. Brown, S. Petterson, S. P. Faux, P. Borm, W. MacNee, F. Michaelangeli, and K. Donaldson, Eur. Respir. Journal 15, 297 (2000).
29. L. C. Renwick, K. Donaldson, and A. Clouter, Toxicol. Appl. Pharmacol. 172, 119 (2001).
30. M. Lundborg, U. Johard, L. P. Lastbom, P. Gerde, and P. Camner, Environ. Res. 86, 244 (2001).
31. W. Möller, T. Hofer, A. Ziesenis, E. Karg, and J. Heyder, Toxicology and Applied Pharmacology 182, 197 (2002).
32. A. E. Nel, D. Diaz-Sanchez, and N. Li, Curr. Opinion Pulm. Med. 7, 20 (2001).
33. P. J. Barnes, Respir. Physiol. 125, 145 (2001).
34. B. Veronesi, C. de Haar, J. Roy, and M. Oortgiesen, Inhal. Toxicol. 14, 159 (2002).
35. M. I. Gilmour, M. Daniels, R. C. McCrillis, D. Winsett, and M. J. K. Selgrade, Environ. Health Perspect. 109 (Suppl. 41), 619 (2001).
36. B. Granum and M. Lovik, Toxicol. Sciences 65, 7 (2002).
37. K. J. Nikula, Inhal. Toxicol. 12, 97 (2000).
38. P. J. A. Borm, R. Schins, and C. Albrecht, Int. J. Cancer 110, 3 (2004).
39. P. M. Hext, Human Exp. Toxicol. 13, 700 (1994).
40. K. E. Driscoll, Inhal. Toxicol. 8, 139 (1996).
41. P. E. Morrow, Toxicol. Appl. Pharmacol. 113, 1 (1992).
42. G. Oberdörster, J. N. Finkelstein, C. Johnston, R. Gelein, C. Cox, R. Baggs, and A. C. P. Elder, Res. Health Eff. Inst. 96 (2001).
43. K. E. Driscoll, L. C. Deyo, J. M. Carter, B. W. Howard, D. G. Hassenbein, and T. A. Bertram, Carcinogenesis 18, 423 (1997).
44. P. J. A. Borm, D. Höhr, Y. Steinfartz, I. Zeitträger, C. and C. Albrecht, Inhal. Toxicol. 12 (Suppl. 3), 225 (2000).
45. A. Don Porto Carrero, P. H. M. Hoet, L. Verschaeve, G. Schoeters, and B. Nemery, Environ. Molec. Mutagenesis 37, 155 (2001).
46. Q. Rahman, M. Lohani, E. Dopp, H. Pemsel, L. Jonas, D. G. Weiss, and D. Schiffmann, Environ. Health Perspect. 110, 797 (2002).
47. M. S. Goldberg, R. T. Burnett, J. C. Bailar, J. Brook, Y. Bonvallot, R. Tamblyn, R. Singh, M. F. Valois, and R. Vincent, Environ. Res. 86, 26 (2001).
48. G. Oberdörster, A. Elder, R. Gelein, A. Lunts, Z. Sharp, V. Atudorei, W. G. Kreyling, and C. Cox, J. Toxicol. Environ. Health A 65, 1531 (2002)
49. W. G. Kreyling, M. Semmler, F. Erbe, P. Mayer, S. Takenaka, G. Oberdörster, and A. Ziesenis, J. Toxicol. Environ. Health 65, 1513 (2002).
50. A. Nemmar, P. H. Hoet, B. Vanquickenborne, D. Dinsdale, M. Thomeer, M. F. Hoylaerts, H. Vanbilloen, L. Mortelmans, and B. Nemery, Circulation 105, 411 (2002).
51. J. S. Brown, K. L. Zeman, and W. D. Bennett, Am. J. Respir. Crit. Care Med. 166, 1240 (2002).
52. A. Nemmar, H. Vanbilloen, M. F. Hoylaerts, P. H. Hoet, A. Verbruggen, and B. Nemery, Am. J. Respir. Crit. Care Med. 164, 1665 (2001).
53. Brooking, S. S. Davis, and L. Illum, J. Drug Target. 9, 267 (2001).
54. M. Gumbleton, Adv. Drug Delivery Rev. 49, 281 (2001).
55. G. Oberdörster and M. J. Utell, Environ. Health Perspect. 110, A440 (2002).
56. H. A. Howe and D. Bodian, Proc. Soc. Exp. Biol. Med. 43, 718 (1940).
57. A. De Lorenzo and J. Darin, in Taste and Smell in Vertebrates, edited by G. E. W. Wolstenholme and J. Knight, London-Churchill, (1970), pp. 151-176.
58. A. Seaton, W. MacNee, K. Donaldson, and D. Godden, Lancet 345, 176 (1995).
59. P. H. Stone and J. J. Godleski, Am. Heart J. 138, 804 (1999).
60. R. D. Brook, J. R. Brook, B. Urch, R. Vincent, S. Rajagopalan, and F. Silverman, Circulation 105, 1534 (2002).
61. J. R. F. Batalha, P. H. N. Saldiva, R. W. Clarke, B. A. Coull, R. C. Stearns, J. Lawrence, G. G. K. Murthy, P. Koutrakis, and J. J. Goldleski, Environ. Health Perspect. 12, 1191 (2002).
62. A. Peters, A. Döring, H. E. Wichmann, and W. Koenig, Lancet 349, 1582 (1997).
63. A. Peters, M. Frohlich, A. Doring, T. Immervoll, H. E. Wichmann, W. L. Hutchinson, M. B. Pepys, and W. Koenig, Eur. Heart J. 22, 1198 (2001).
64. A. Peters, D. W. Dockery, J. E. Muller, and M. A. Mittleman, Circulation 103, 2810 (2001).
65. C. A. Pope 3rd, R. L. Verrier, E. G. Lovett, A. C. Larson, M. E. Raizenne, R. E. Kanner, J. Schwartz, G. M. Villegas, D. R. Gold, and D. W. Dockery, Am. Heart J. 138, 890 (1999).
66. L. Clancy, P. Goodman, H. Sinclair, and D. W. Dockery, Effect of air-pollution control on death rates in Dublin, Ireland: an intervention study. Lancet 360, 1210 (2002).
67. B. Fubini, A. E. Aust, R. E. Bolton, P. J. A. Borm, J. Bruch, G. Ciapetti, K. Donaldson, Z. Elias, J. Gold, M. C. Jaurand, A. B. Kane, D. Lison, and H. Muhle, ATLA 26, 579 (1998).
68. A. Searl, D. Buchanan, R. T. Cullen, A. D. Jones, B. G. Miller, and C. A. Soutar, Ann. Occup. hyg. 43, 143 (1999).
69. R. M. Potter and S. M. Mattson, Glastech. Ber 64, 16 (1991).
70. R. W. Atkinson, H. R. Anderson, J. Sunyer, J. Ayres, M. Baccini, J. M. Vonk, A. Boumghar, F. Forastiere, B. Forsberg, G. Touloumi, J. Schwartz, and K. Katsouyanni, Am. J. Respir. Crit. Care Med. 164, 1860 (2001).
71. A. L. Braga, A. Zanobetti and J. Schwartz, Occup. Environ. Med. 43, 927 (2001).
72. A. Zanobetti, J. Schwartz, and D. W. Dockery, Environ. Health Perspect. 108, 1071 (2000).
73. R. D. Morris, Environ. Health Perspect. 109 (Suppl. 4), 495 (2001).
74. F. J. Miller, Inhal. Toxicol. 12, 19 (2000).
75. V. Stone, J. Shaw, D. M. Brown, and K. Donaldson, Toxicol. In Vitro 12, 649 (2000).
76. H. Behrendt and W. M. Becker, Curr. Opin. Immunol. 13, 709 (2001).
77. N. Li, C. Sioutas, A. Cho, D. Schmitz, C. Misra, J. Sempf, M. Wang, T. Oberley, J. Froines, and A. Nel, Environ. Health Perspect.
78. M. R. Wilson, J. H. Lightbody, K. Donaldson, J. Sales, and V. Stone, Toxicol. Appl. Pharmacol. 184, 172 (2002).